Comparison of geographic atrophy growth rates using different imaging modalities in the COMPLETE study

Ophthalmic Surgery Lasers and Imaging Retina

Volumn 46, Issue 4, 2015, Pages 413-422

  Yehoshua, Zohar ^a   De Amorim Garcia Filho, Carlos Alexandre ^a,b   Nunes, Renata Portella ^a   Gregori, Giovanni ^a   Penha, Fernando M ^a,b   Moshfeghi, Andrew A ^a   Sadda, SriniVas ^c   Feuer, William ^a   Rosenfeld, Philip J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE RELATED MACULAR DEGENERATION; ARTICLE; AUTOFLUORESCENCE IMAGING; CLINICAL ARTICLE; CONFOCAL SCANNING LASER OPHTHALMOSCOPE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; FUNDUS AUTOFLUORESCENCE; FUNDUS CAMERA; GEOGRAPHIC ATROPHY; GROWTH RATE; HUMAN; PRIORITY JOURNAL; SCANNING LASER OPHTHALMOSCOPY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; AGED; CLASSIFICATION; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; FLUORESCENCE IMAGING; MIDDLE AGED; MULTIMODAL IMAGING; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA;

COMPLEMENT INHIBITOR; ECULIZUMAB; MONOCLONAL ANTIBODY;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; COMPLEMENT INACTIVATING AGENTS; DOUBLE-BLIND METHOD; FLUORESCEIN ANGIOGRAPHY; GEOGRAPHIC ATROPHY; HUMANS; MIDDLE AGED; MULTIMODAL IMAGING; OPHTHALMOSCOPY; OPTICAL IMAGING; PROSPECTIVE STUDIES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84929404866     PISSN: 23258160     EISSN: 23258179     Source Type: Journal    
DOI: 10.3928/23258160-20150422-03     Document Type: Article

References (55)

1. Holz FG. [Autofluorescence imaging of the macula]. Ophthalmologe. 2001;98(1):10-18.
2. Rein DB, Wittenborn JS, Zhang X, et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol. 2009;127(4):533-540.
3. Chakravarthy U, Harding SP, Rogers CA, et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet. 2013;382(9900):1258-1267.
4. Grunwald JE, Daniel E, Huang J, et al. Risk of geographic atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology. 2014;121(1):150-161.
5. Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis. 1999;5:25.
6. Fleckenstein M, Schmitz-Valckenberg S, Adrion C, et al. Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51(8):3846-3852.
7. Klein ML, Ferris FL, 3rd, Armstrong J, et al. Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology. 2008;115(6):1026-1031.
8. Yehoshua Z, Rosenfeld PJ, Gregori G, et al. Progression of geographic atrophy in age related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology. 2011;118(4):679-686.
9. Age-Related Eye Disease Study 2 Research G. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005-2015.
10. Klein R, Meuer SM, Knudtson MD, Klein BE. The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am J Ophthalmol. 2008;146(5):692-699.
11. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102(10):1450-1460.
12. Klaver CC, Assink JJ, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2001;42(10):2237-2241.
13. Lindblad AS, Lloyd PC, Clemons TE, et al. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol. 2009;127(9):1168-1174.
14. Pirbhai A, Sheidow T, Hooper P. Prospective evaluation of digital non-stereo color fundus photography as a screening tool in age-related macular degeneration. Am J Ophthalmol. 2005;139(3):455-461.
15. Scholl HP, Peto T, Dandekar S, et al. Inter- and intra-observer variability in grading lesions of age-related maculopathy and macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2003;241(1):39-47.
16. Sunness JS, Bressler NM, Tian Y, et al. Measuring geographic atrophy in advanced age-related macular degeneration. Invest Ophthalmol Vis Sci. 1999;40(8):1761-1769.
17. Schmitz-Valckenberg S, Fleckenstein M, Gobel AP, et al. Evaluation of autofluorescence imaging with the scanning laser ophthalmoscope and the fundus camera in age-related geographic atrophy. Am J Ophthalmol. 2008;146(2):183-192.
18. Deckert A, Schmitz-Valckenberg S, Jorzik J, et al. Automated analysis of digital fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration using confocal scanning laser ophthalmoscopy (cSLO). BMC Ophthalmol. 2005;5:8.
19. Schmitz-Valckenberg S, Jorzik J, Unnebrink K, et al. Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2002;240(2):73-78.
20. Delori FC, Dorey CK, Staurenghi G, et al. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36(3):718-729.
21. Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci. 2000;41(7):1981-1989.
22. Schmitz-Valckenberg S, Bultmann S, Dreyhaupt J, et al. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45(12):4470-4476.
23. Rudolf M, Vogt SD, Curcio CA, et al. Histologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophy. Ophthalmology. 2013;120(4):821-828.
24. Holz FG, Bellmann C, Margaritidis M, et al. Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1999;237(2):145-152.
25. Bindewald A, Schmitz-Valckenberg S, Jorzik JJ, et al. Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration. Br J Ophthalmol. 2005;89(7):874-878.
26. Bearelly S, Khanifar AA, Lederer DE, et al. Use of fundus autofluorescence images to predict geographic atrophy progression. Retina. 2011; 1(1):81-86.
27. Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF. Fundus autofluorescence imaging: review and perspectives. Retina. 2008; 8(3):385-409.
28. Lujan Bj, Rosenfeld PJ, Giovanni G, et al. Spectral domain optical coherence tomographic imaging of geographic atrophy. Ophthalmic Surg Lasers Imaging. 2008;39(4 Suppl):S8-S14.
29. Bearelly S, Chau FY, Koreishi A, et al. Spectral domain optical coherence tomography imaging of geographic atrophy margins. Ophthalmology. 2009;116(9):1762-1769.
30. Fleckenstein M, Charbel Issa P, Helb HM, et al. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49(9):4137-4144.
31. Helb HM, Charbel Issa P, Fleckenstein M, et al. Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectral-domain optical coherence tomography. Acta Ophthalmol. 2010;88(8):842-849.
32. Jiao S, Knighton R, Huang X, et al. Simultaneous acquisition of sectional and fundus ophthalmic images with spectral-domain optical coherence tomography. Opt Express. 2005;13(2):444-452.
33. Wojtkowski M, Srinivasan V, Fujimoto JG, et al. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2005;112(10):1734-1746.
34. Yehoshua Z, Garcia Filho CA, Penha FM, et al. Comparison of geographic atrophy measurements from the OCT fundus image and the sub-RPE slab image. Ophthalmic Surg Lasers Imaging Retina. 2013;4(2):127-132.
35. Sayegh RG, Simader C, Scheschy U, et al. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. Ophthalmology. 2011; 18(9):1844-1851.
36. Hu Z, Medioni GG, Hernandez M, Hariri A, Wu X, Sadda SR. Segmentation of the Geographic Atrophy in Spectral-domain Optical Coherence Tomography and Fundus Autofluorescene Images. Invest Ophthalmol Vis Sci. 2013;54(13):8375-8383.
37. Schutze C, Bolz M, Sayegh R, et al. Lesion size detection in geographic atrophy by polarization-sensitive optical coherence tomography and correlation to conventional imaging techniques. Invest Ophthalmol Vis Sci. 2013;54(1):739-745.
38. Khanifar AA, Lederer DE, Ghodasra JH, et al. Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area. Retina. 2012;32(9):1884-1891.
39. Yehoshua Z, Alexandre de Amorim Garcia Filho C, Nunes RP, et al. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. Ophthalmology. 2014;121(3):693-701.
40. Yehoshua Z, Rosenfeld PJ, Gregori G, et al. Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology. 2011;118(4):679-686.
41. Li Y, Gregori G, Knighton RW, et al. Registration of OCT fundus images with color fundus photographs based on blood vessel ridges. Opt Express. 2011;19(1):7-16.
42. Feuer WJ, Yehoshua Z, Gregori G, et al. Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26. JAMA Ophthalmol. 2013;131(1):110-111.
43. Fleiss J. Statistical measures for rates and proportions, second ed. New York: John Wiley & Sons, 1981.
44. Brader HS, Ying GS, Martin ER, et al. New grading criteria allow for earlier detection of geographic atrophy in clinical trials. Invest Ophthalmol Vis Sci. 2011;52(12):9218-9225.
45. Schmitz-Valckenberg S, Fleckenstein M, Gobel AP, et al. Optical coherence tomography and autofluorescence findings in areas with geographic atrophy due to age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(1):1-6.
46. Holz FG, Bellman C, Staudt S, et al. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2001;42(5):1051-1056.
47. Holz FG, Bindewald-Wittich A, Fleckenstein M, et al. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol. 2007;143(3):463-472.
48. Brar M, Kozak I, Cheng L, et al. Correlation between spectral-domain optical coherence tomography and fundus autofluorescence at the margins of geographic atrophy. Am J Ophthalmol. 2009;148(3):439-444.
49. Dreyhaupt J, Mansmann U, Pritsch M, et al. Modelling the natural history of geographic atrophy in patients with age-related macular degeneration. Ophthalmic Epidemiol. 2005;12(6):353-362.
50. Fleckenstein M, Schmitz-Valckenberg S, Martens C, et al. Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy. Invest Ophthalmol Vis Sci. 2011;52(6):3761-3766.
51. Schmitz-Valckenberg S, Bindewald-Wittich A, Dolar-Szczasny J, et al. Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci. 2006;47(6):2648-2654.
52. Nunes RP, Gregori G, Yehoshua Z, et al. Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina. Ophthalmic Surg Lasers Imaging Retina. 2013;44(4):344-359.
53. Wolf-Schnurrbusch UE, Enzmann V, Brinkmann CK, Wolf S. Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci. 2008;49(7):3095-3099.
54. van der Burght BW, Hansen M, Olsen J, et al. Early changes in gene expression induced by blue light irradiation of A2E-laden retinal pigment epithelial cells. Acta Ophthalmol. 2013;91(7):e537-545.
55. Rozanowska M, Jarvis-Evans J, Korytowski W, et al. Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem. 1995;270(32):18825-18830.